明确手术在初诊IV期乳腺癌中的作用：对生物标志物和机制性见解的需求 - Suppr

Suppr

超能文献

Refining the role of surgery in de novo stage IV breast cancer: the need for biomarkers and mechanistic insights.

作者信息

Rizk Mariam, Mokbel Kefah

机构信息

The London Breast Institute, Princess Grace Hospital, London, W1U 5NY, UK.

出版信息

Breast Cancer. 2025 May;32(3):613-614. doi: 10.1007/s12282-025-01681-y. Epub 2025 Feb 17.

DOI:10.1007/s12282-025-01681-y

PMID:39962025

Abstract

摘要

相似文献

Refining the role of surgery in de novo stage IV breast cancer: the need for biomarkers and mechanistic insights.明确手术在初诊IV期乳腺癌中的作用：对生物标志物和机制性见解的需求

Breast Cancer. 2025 May;32(3):613-614. doi: 10.1007/s12282-025-01681-y. Epub 2025 Feb 17.

Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.曲妥珠单抗为基础的治疗用于 HER2 阳性初治或复发的 IV 期乳腺癌女性的临床结局。

Breast. 2014 Feb;23(1):44-9. doi: 10.1016/j.breast.2013.10.005. Epub 2013 Nov 7.

Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002).初诊 IV 期乳腺癌患者的临床信息和管理现状：一项中国多中心调查（CSBrS-002）。

Chin Med J (Engl). 2021 Jun 7;134(13):1569-1575. doi: 10.1097/CM9.0000000000001415.

The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer.乳房手术和全身治疗对初诊IV期乳腺癌患者生存的影响。

Breast Cancer. 2025 Mar;32(2):426-433. doi: 10.1007/s12282-025-01675-w. Epub 2025 Feb 2.

Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.转移性模式可区分新诊断 IV 期乳腺癌行原发性手术的生存获益：一项真实世界观察性研究。

Eur J Surg Oncol. 2019 Aug;45(8):1364-1372. doi: 10.1016/j.ejso.2019.02.013. Epub 2019 Feb 19.

Radiation therapy for primary tumor of stage IV breast cancer.IV期乳腺癌原发肿瘤的放射治疗。

Transl Cancer Res. 2020 Aug;9(8):5108-5116. doi: 10.21037/tcr.2020.02.54.

Brain metastasis in de novo stage IV breast cancer.初诊 IV 期乳腺癌脑转移。

Breast. 2023 Oct;71:54-59. doi: 10.1016/j.breast.2023.07.005. Epub 2023 Jul 14.

Role of Locoregional Treatment in De Novo Stage IV Breast Cancer.局部区域治疗在初治IV期乳腺癌中的作用

Clin Med Insights Oncol. 2020 Sep 17;14:1179554920942440. doi: 10.1177/1179554920942440. eCollection 2020.

Survival differences among women with de novo stage IV and relapsed breast cancer.初诊 IV 期和复发乳腺癌女性的生存差异。

Ann Oncol. 2010 Nov;21(11):2169-2174. doi: 10.1093/annonc/mdq220. Epub 2010 Apr 28.

Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.原发肿瘤切除术治疗初诊 IV 期乳腺癌患者可减轻局部症状并提高生活质量。

Ann Surg Oncol. 2020 Apr;27(4):1025-1033. doi: 10.1245/s10434-019-08092-2. Epub 2020 Jan 22.

本文引用的文献

The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer.乳房手术和全身治疗对初诊IV期乳腺癌患者生存的影响。

Breast Cancer. 2025 Mar;32(2):426-433. doi: 10.1007/s12282-025-01675-w. Epub 2025 Feb 2.

Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.通过联合监测基线循环肿瘤细胞和 DNA 对晚期乳腺癌患者进行风险分层和临床结局的早期评估。

Clin Cancer Res. 2024 Aug 15;30(16):3470-3480. doi: 10.1158/1078-0432.CCR-24-0535.

Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis.216066 例初诊 IV 期乳腺癌患者原发肿瘤局部区域治疗：一项荟萃分析。

Sci Rep. 2020 Feb 19;10(1):2952. doi: 10.1038/s41598-020-59908-1.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.原发肿瘤诱导的免疫可清除同种小鼠模型中的播散肿瘤细胞。

Nat Commun. 2019 Mar 29;10(1):1430. doi: 10.1038/s41467-019-09015-1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验